Navigation Links
Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
Date:9/8/2008

studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. /R E P E A T -- Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours/
2. Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
3. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
4. Oncolytics Biotech Inc. Announces 2008 Second Quarter Results
5. Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies with REOLYSIN(R)
6. Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
7. Oncolytics Biotech Inc. to Present at BIO 2008 International Convention
8. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)
9. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
10. Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting
11. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... potential revenue from new rodenticide research are premature. In ... on July 22, 2014, Neogen,s CEO commented about several ... "It was my intent Tuesday at our ... a new type of rodenticide, but certainly not to ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 1000 balances ... takes input on customers’ weighing needs and expertly narrows ... shortlist of balances, scales or even terminals. , ... and smallest weight (or select readability instead) and define ... few additional selection criteria narrows down the list to ...
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 ... http://www.draperuniversity.com , is proud to announce that for ... 17 different countries will converge on the Draper ... for an intensive, experiential program focused on entrepreneurship, ... highly selective school, currently running its sixth cohort, ...
(Date:7/24/2014)...   Cypher Genomics, Inc., the genome ... Adam Simpson as president and chief operating ... annotation and interpretation of individual human genomes for ... technology has the potential to play a transformative ... optimizing therapeutic approaches and reducing adverse drug reactions," ...
Breaking Biology Technology:Neogen comments on SenesTech 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3
... Calif., Sept. 27 Poniard,Pharmaceuticals, Inc. (Nasdaq: ... announced that the Company,s common shares are now,eligible ... and will begin trading,there under the same symbol ... for listing on the NASDAQ Global Market represents ...
... 454 Life Sciences, a Roche,company, in collaboration with ... a method, using the company,s Genome Sequencer(TM),FLX system, ... level of detail. The new method enables researchers ... to the,genetic code in a very fast and ...
... strategic plan, WATERTOWN, Mass., Sept. 27 ... Biomedical Research Institute, an independent,not-for- profit biomedical research ... scientists, a 23% increase in its scientific staff. ... fruits of a three-year,strategic planning process designed to ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market 2454 Sequencing(TM): Science Paper Suggests That Structural Variation Plays an Important Role in Genetic Variation 2454 Sequencing(TM): Science Paper Suggests That Structural Variation Plays an Important Role in Genetic Variation 3New Scientists Boost Disease-based Research at Boston Biomedical Research Institute 2New Scientists Boost Disease-based Research at Boston Biomedical Research Institute 3
(Date:7/25/2014)... research at the University of Adelaide has opened the way ... to powdery mildew. , In Australia, annual barley production is ... Powdery mildew is one of the most important diseases of ... have discovered the composition of special growths on the cell ... fungus into the leaf. , The research, by the ARC ...
(Date:7/25/2014)... age girls reach puberty is influenced by ,imprinted genes,a subset ... the gene. This is the first evidence that imprinted ... details of this study were published today in the journal ... as menarche, is a marker for the timing of puberty ... menses varies between girls, is an inherited trait, and is ...
(Date:7/25/2014)... , July 25, 2014 ... consumers are turning to digital technology for online & ... NXTD), Google Inc. (NASDAQ: GOOG ), LifeLock ... V ), Apple Inc. (NASDAQ: ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused ...
Breaking Biology News(10 mins):New hope for powdery mildew resistant barley 2Could age of first period influence development of diseases in older women? 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6
... Plasmodium falciparum uses different pathways to invade ... complicating efforts to create effective vaccines against the disease. ... an international research scholar with the Howard Hughes Medical ... to switch back and forth between invasion pathways. ...
... process that has stumped scientists for many years: exactly ... cell's nucleus, where it has strong anti-carcinogenic effects. , ... door for future research on related compounds. The finding ... other diseases. , The research, which appears in a ...
... porphyria , Dana-Farber Cancer Institute researchers say they have ... irrational and demented behavior in porphyria, the disease believed ... ruler blamed for the loss of the American colonies ... symptoms of porphyria, a rare genetic blood disease which ...
Cached Biology News:Gene expands malaria's invasion options 2Gene expands malaria's invasion options 3Study shows how retinoic acid enters a cell's nucleus 2Study shows how retinoic acid enters a cell's nucleus 3Attacks of King George III's madness linked to key metabolism molecule 2Attacks of King George III's madness linked to key metabolism molecule 3
... the original Gene Pulser apparatus and accessory modules ... applied in the Gene Pulser II system, which ... the Gene Pulser II system has the dual ... widest range of settings to target specific cell ...
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
... the submicron range are part of your ... control of particle size is important to ... reliably detect the component populations in your ... Size Analyzer uses Photon Correlation Spectroscopy (PCS) ...
...
Biology Products: